Taiwan-based medical device manufacturing company Apex Medical Corporation officially launched their operations in India on Wednesday,11 March, 2015 with their product verticals – Respiratory, Support Surface, and Autoclaves.
With an initial investment of Rs 100 crore, the company aims to market equipments to various hospitals and nursing homes. Apex Medical would venture into the Indian healthcare market with its products such as nebulizers in the field of respiratory therapy, bubble mattresses for bedridden patients and table top sterilization equipments for dentistry etc.
Daniel Lee, CEO, Apex Medical Corp said, “We look forward to be a part of the continuously growing Indian healthcare industry and we see more opportunities with the new government that is willing to make a big change.”
The ‘Make in India’ initiative by Prime Minister Narendra Modi and the market growing by 12-15 per cent every year, Apex is open to every option like joint venture with other manufacturing companies or acquiring small Indian companies, he added.
The company invests five per cent of its annual revenue on research and development, also has a network of international subsidiaries and partners in Europe, United States, and other markets.
“We are excited to introduce FDA and CE approved Apex products with technological excellence to customers in India at affordable prices with high service standards,” Puneet Sahai, President, Apex Medical India.